<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC7765155/figure_8" xmlns="http://www.w3.org/1999/xhtml">
 <caption> Methodological design based on the biotechnological strategy “increasing income and reducing expenditure” proposed by Zhang et al. [ 200] for improving RA production. CCR, cinnamoyl-CoA reductase; CCoAMT, caffeoyl-CoA O methyltransferase; C3′H, coumarate 3′-hydroxylase; C4H, cinnamate 4-hydroxylase; 4CL, hydroxycinnamate-CoA ligase; COMT, caffeic acid O-methyltransferase; GT, glycosyl transferase; HCT, hydroxycinnamoyl transferase; HPPR, hydroxyphenylpyruvate reductase; PAL, phenylalanine ammonia lyase; RAS, rosmarinic acid synthase; TAT, tyrosine aminotransferase. </caption>
 <div class="graphic"/>
 <p class="label">Figure 8</p>
</div>
